ANI Pharmaceuticals ANIP Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndTaxCredits.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's deferred taxes?
- ANI Pharmaceuticals (ANIP) reported deferred taxes of $2.52M in Q1 2026.
- How has ANI Pharmaceuticals's deferred taxes changed year-over-year?
- ANI Pharmaceuticals's deferred taxes increased by 174.3% year-over-year, from -$3.38M to $2.52M.
- What is the long-term trend for ANI Pharmaceuticals's deferred taxes?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's deferred taxes has grown at a -4.0% compound annual growth rate (CAGR), from -$16.75M to $14.24M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.